HULIO Trademark

Trademark Overview

On Wednesday, November 11, 2020, a trademark application was filed for HULIO with the United States Patent and Trademark Office. The USPTO has given the HULIO trademark a serial number of 79299356. The federal status of this trademark filing is REGISTERED as of Tuesday, October 12, 2021. This trademark is owned by FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.. The HULIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of autoimmune and inflammatory diseases; Pharmaceutical preparations comprised of a monoclonal antibody to a tumor necrosis factor alpha for treatment of autoimmune and inflammatory diseases
hulio

General Information

Serial Number79299356
Word MarkHULIO
Filing DateWednesday, November 11, 2020
Status700 - REGISTERED
Status DateTuesday, October 12, 2021
Registration Number6513556
Registration DateTuesday, October 12, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 27, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of autoimmune and inflammatory diseases; Pharmaceutical preparations comprised of a monoclonal antibody to a tumor necrosis factor alpha for treatment of autoimmune and inflammatory diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 4, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameFUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameFUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Monday, December 4, 2023INTERNATIONAL REGISTRATION RENEWED
Thursday, July 14, 2022REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED
Tuesday, June 14, 2022PETITION TO DIRECTOR GRANTED
Tuesday, June 14, 2022ASSIGNED TO PETITION STAFF
Sunday, May 15, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, April 28, 2022TEAS PETITION TO DIRECTOR RECEIVED
Monday, March 28, 2022GENERIC MADRID TRANSACTION SENT TO IB
Monday, March 28, 2022GENERIC MADRID TRANSACTION CREATED
Wednesday, January 12, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 12, 2021REGISTERED-PRINCIPAL REGISTER
Saturday, August 7, 2021NOTIFICATION PROCESSED BY IB
Tuesday, July 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, July 7, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 7, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 24, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 24, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, June 24, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 24, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, June 24, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 23, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, June 23, 2021FINAL REFUSAL E-MAILED
Wednesday, June 23, 2021FINAL REFUSAL WRITTEN
Monday, May 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 24, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 24, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, May 16, 2021REFUSAL PROCESSED BY IB
Thursday, April 22, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, April 22, 2021REFUSAL PROCESSED BY MPU
Thursday, April 22, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, April 21, 2021NON-FINAL ACTION WRITTEN
Wednesday, April 21, 2021ASSIGNED TO EXAMINER
Tuesday, December 8, 2020APPLICATION FILING RECEIPT MAILED
Friday, December 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 3, 2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

hulio diseases pharmaceutical autoimmune inflammatory treatment preparations factor alpha necrosis comprised